BioLife Solutions (BLFS) Misses Q2 EPS by 2c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $38.61 --0%
Revenue Growth %: +3.9%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
SICP, MNSB, CFFI, More
Revenue Growth %: +3.9%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $43.64 million.
GUIDANCE:
BioLife Solutions sees FY2023 revenue of $144-158 million, versus the consensus of $184.1 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roper Technologies (ROP) Tops Q3 EPS by 10c ; Offers Guidance
- Norfolk Southern (NSC) Tops Q3 EPS by 14c
- Procter & Gamble (PG) Tops Q1 EPS by 11c, updates guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
